The promise of anti-ErbB3 monoclonals as new cancer therapeutics-Reference-Cited by-同舟云学术

The promise of anti-ErbB3 monoclonals as new cancer therapeutics

Author:

Aurisicchio Luigi¹²,Marra Emanuele¹,Roscilli Giuseppe¹,Mancini Rita³,Ciliberto Gennaro⁴⁵

Affiliation:

1. Takis s.r.l., Via di Castel Romano 100, Roma, Italy

2. BIOGEM scarl, via Camporeale, Ariano Irpino (Av), Italy

3. Dipartimento di Medicina Clinica e Molecolare, Facoltà di Medicina e Psicologia, Università degli Studi di Roma “La Sapienza”, Roma

4. IRCCS Istituto Nazionale Tumori, Fondazione “G. Pascale”, Napoli, Italy

5. Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Catanzaro“Magna Graecia”, Catanzaro, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. HER3 in cancer: from the bench to the bedside;Journal of Experimental & Clinical Cancer Research;2022-10-21

3. New Scope of Targeted Therapies in Lung Carcinoma;Mini-Reviews in Medicinal Chemistry;2021-08-05

4. Expression of estrogen receptors in Spitz and Reed nevi;Italian Journal of Dermatology and Venereology;2021-07